We make health research accessible to everyone, everywhere.

New treatments would not be possible without volunteers like you. By joining our community you will get access to clinical trials that are right for you.

Help discover cutting edge treatments

Benefit from treatments not available elsewhere

Learn about your health and medical conditions

Frequently asked questions

Please feel free to contact us with any questions you may have that we haven’t covered below.

What is a clinical trial?

A clinical trial is a medical study comparing the effect of different healthcare treatments. They are essential for finding new, safer and more effective treatments for all kinds of health conditions.

Will I be paid for participating in research?

Most trials and studies will cover your travel expenses and other expenses you may incur from participation. Some offer additional compensation. Full details of compensation can be found on the relevant study page.

Who can take part in a clinical trial or study?

Every clinical trial has unique requirements for taking part, called the ‘inclusion’ and ‘exclusion’ criteria. If you don't qualify for one trial you're interested in, you may qualify for another in your area. You can also fill out your profile here to sign up for alerts from Lindus Health when new trials match your profile.

Is it safe to take part in a clinical trial?

Yes. The safety of participants is very important. Before any clinical trial can begin, plans must be approved by medical regulators and ethics committees. All participants in clinical trials are under the care of the trial teams, who must include qualified doctors and clinicians. The care they receive must be at least as good as care received by the general population.

Can I change my mind about taking part?

Yes, you can still leave a clinical trial at any time, for any reason.

How much time does it take to participate in a trial or study?

Time commitment varies across clinical trials. Full details of time commitments are available on the study page, or you can ask the study staff.

What is a control arm or placebo?

A ‘control arm’ or ‘placebo’ is often used to fairly assess how effective a treatment is. In some clinical trials, up to half the participants may receive an existing treatment or a placebo (a dummy treatment). The results of these participants are compared against the participants who had the new treatment. This helps remove bias and fairly assess how well the new treatment works.

What do you do with my data?

We ask for your permission before collecting and storing any of your data, and sharing it with the study teams. All results are completely confidential. For full details, please see our privacy policy. Volunteers for clinical trials and studies are essential to moving healthcare forward. If you're ready to get involved, start searching for a trial that matches you today.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headshot Hayley Holt

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headshot Ece Kavalci

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headhshot Meri Beckwith

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headshot Rebbeca de Rome

Our current trials.

Von Willebrand Disease (VWD) and Heavy Menstrual Bleeding

Five Liters, a pioneer in wearable neurostimulation for
bleeding disorders, invites you to participate in an
extraordinary clinical trial focusing on the impacts of
wearable neurostimulation on heavy menstrual bleeding and
VWD.
We need forward-thinking women diagnosed with Type 1
VWD who also experience heavy menstrual bleeding to help
us validate this novel treatment option from the comfort of
home.
Eligible participants who complete the study will be
compensated a total $200 for their time.

Click here to take part

Study For

Women aged 18-45 with VWD & Heavy Menstrual Bleeding

Sponsored By

Five Liters

Participants

10

 people

Participate by

The PAPI Study - Mental Health Tool

Welcome to the PAPI Study. During this study, you will have the opportunity to use a mobile app, which provides access to information and tools to help manage mood through a chatbot. 

The purpose of this research study is to understand how adults may use a chatbot in daily life.

The study will be four weeks long and fully remote. During the study period, you will be asked to complete 4 questionnaires about your mood, emotions, and your experience with using the app.  

You will be compensated up to $50, in the form of a gift card, for full participation in the study.

Click here to take part

Study For

Adults ages 18 - 75

Sponsored By

Woebot Health

Participants

200

 people

Participate by

March 31, 2024

STAMP: STI and HPV screening with tampons

This trial aims to investigate whether tampons can be used to diagnose a range of common vaginal infections (HPV, BV, chlamydia and gonorrhoea).

Developing an effective and user-friendly way of testing for these infections using tampons could significantly improve women's health outcomes. As many women already use tampons on a monthly basis, using them in this way could increase testing uptake and enhance early detection and treatment of infections.

You will be compensated £50 for full participation in the study as well as reasonable travel expenses.

Click here to take part

Study For

Women aged 25-65

Sponsored By

Tampon Innovations which is a subsidiary of DAYE

Participants

325

 people

Participate by

February 16, 2024

PAX-D study: treatment resistant depression

The purpose of this study is to find out if pramipexole is a useful treatment for treatment resistant depression (TRD). A significant proportion of people diagnosed with clinical depression (up to 3 in 10) do not improve with current first-line treatments and are regarded as having TRD. Current medicines for TRD are not particularly effective for many people and often have unwanted effects which may be distressing.

There is some evidence that pramipexole may be an effective treatment for TRD. Pramipexole is unlike current antidepressant drugs in that it acts like a brain chemical called dopamine, which is known to influence people’s motivation to pursue goals and affects how rewarding they find them. This study will require visits to the Campus of Ageing and Vitality, (formerly Newcastle General Hospital), Westgate Road, Newcastle Upon Tyne, NE4 6BE.

Click here to take part

Study For

Adults with treatment resistant depression

Sponsored By

University of Oxford

Participants

204

 people

Participate by

March 1, 2024

The DEFINE Trial - Digital Therapy For Improved Tinnitus Care

Tinnitus therapy, including Cognitive Behavioural Therapy (CBT) is an effective treatment for helping people to manage tinnitus. This study aims to compare the effectiveness of a new digital tinnitus therapy, The Oto Tinnitus Programme, to conventional tinnitus therapy.

The Oto Tinnitus Programme is a digital approach to tinnitus management that delivers therapies through a self-paced smartphone app.

The DEFINE study will randomly assign adults with tinnitus to receive the Oto programme or therapist-delivered conventional tinnitus therapy, evaluating both their effectiveness in reducing tinnitus severity as well as the financial implications of both approaches.

Participants will be required to complete electronic surveys throughout the 12-month study period while receiving therapy for their tinnitus. You will be compensated £40 for your time.

Click here to take part

Study For

Adults with tinnitus persisting for at least 3 months and severe enough to impact their daily life.

Sponsored By

Oto Health

Participants

196

 people

Participate by

December 31, 2023

Y-META: A study for people who are overweight or have pre-diabetes

Research has suggested that poor gut health may be involved in problems associated with high blood sugar which, left untreated can lead to the development of Type 2 Diabetes (T2D).  

The University of Roehampton is investigating if a natural supplement can help maintain good gut health. The study team are looking for pre-diabetic or overweight adults to take part.

The study involves 4 short visits over a period of 16 weeks at the University of Roehampton.  

You will be given a £50 amazon voucher for your time.

Click here to take part

Study For

Adults who have pre-diabetes or who are overweight

Sponsored By

The University of Roehampton

Participants

25

 people

Participate by

December 31, 2023

PROGRESS: A study for people who have recovered from depression

The University of Oxford is looking for healthy volunteers aged 18-55 years, who have recovered from two or more episodes of depression, for a study investigating how a licensed drug (prucalopride) affects thinking and emotion.

The study involves 2 study visits over a period of 1-2 weeks at the Warneford Hospital Site, Oxford.

You will be reimbursed £125 for your time and inconvenience. Reasonable travel expenses will be reimbursed.

Click here to take part

Study For

Adults who have recovered from depression

Sponsored By

The University of Oxford

Participants

50

 people

Participate by

December 31, 2023

CABIN study: researching new treatment for people with low mood

This study is researching how antidepressants and behavioural therapy affect people who are experiencing low mood. The study hopes to develop better personalised treatment for low mood.

The study is looking for people who are feeling low in mood but who are not currently taking any medication to treat depression or receiving any type of psychological therapy. The study will involve 6 research visits, 1 in person at the research site at the University of Oxford and 5 online. You will receive £150 for participation.

Click here to take part

Study For

Adults with low mood, who are not currently receiving any medication or therapy.

Sponsored By

University of Oxford

Participants

135

 people

Participate by

December 30, 2023

PAX-D study: treatment resistant depression

The purpose of this study is to find out if pramipexole is a useful treatment for treatment resistant depression (TRD). A significant proportion of people diagnosed with clinical depression (up to 3 in 10) do not improve with current first-line treatments and are regarded as having TRD. Current medicines for TRD are not particularly effective for many people and often have unwanted effects which may be distressing.

There is some evidence that pramipexole may be an effective treatment for TRD. Pramipexole is unlike current antidepressant drugs in that it acts like a brain chemical called dopamine, which is known to influence people’s motivation to pursue goals and affects how rewarding they find them. This study will require visits to Oxford.

Click here to take part

Study For

Adults with treatment resistant depression

Sponsored By

University of Oxford

Participants

204

 people

Participate by

May 1, 2024